Rhythm Pharmaceuticals Inc.
RYTM | NASDAQ
$105.02
-$5.66 (-5.11%)
At close: Nov 5, 2026, 4:00 PM ET
$104.97
-$0.05 (-0.05%)
After-hours:
Nov 5, 2026, 5:53 PM ET
Fiscal Quarter Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 14.27M | -104.94M | -55.64M | -47.51M | -52.9M | -46.63M | -49.5M | -43.29M | -43.68M | -32.26M | -141.37M | -41.63M | -44.16M | -46.7M | -52.18M | -42.49M | -40.86M | -45M | -52.76M | -42.87M | -35.11M | -35.39M | 43.75M |
Depreciation & Amortization | 248K | 251K | 252K | 272K | 304K | 379K | 383K | 383K | 385K | 390K | 405K | 417K | 442K | 442K | 457K | 442K | 442K | 438K | 350K | 325K | 315K | 317K | 201K |
Stock-Based Compensation | 1.93M | 49.16M | 23.1M | 19.27M | 18.81M | 15.88M | 12.86M | 10.56M | 11M | 10.36M | 7.77M | 8.67M | 8.61M | 8.89M | 6.38M | 5.29M | 4.8M | 5.14M | 4.61M | 4.68M | 5.27M | 5.67M | 5.19M |
Other Working Capital | -2.36M | 2.56M | -197K | -3.19M | 1.14M | -1.38M | -4.39M | -919K | 802K | 3.76M | -1.23M | 9.95M | -3.37M | -1.6M | 2.05M | -3.55M | -1.32M | 5.47M | -5.71M | -6.21M | -7.57M | -3.03M | 1.65M |
Other Non-Cash Items | 1.31M | 8.55M | 5.11M | 3.27M | 4.06M | 2.54M | 3.81M | 3.3M | 2.38M | -5.42M | 94.65M | -5.75M | 7.44M | 3.49M | 6.16M | 2.88M | 3.12M | -19K | -65K | 4.87M | -63K | -61K | -100.06M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 135K | n/a | n/a | n/a | n/a | n/a | n/a | -9M | -5.02M | 22.01M |
Change in Working Capital | 23.37M | -6.36M | -17.01M | -691K | 3.11M | 4.53M | -7.91M | 10.21M | 4.7M | -2.15M | -2.19M | 8.91M | -1.58M | -7.34M | 2.75M | -116K | -14.48M | 636K | -5.76M | -7.47M | -1.58M | 2.65M | -4.62M |
Operating Cash Flow | 41.12M | -53.34M | -44.19M | -25.39M | -26.62M | -23.31M | -40.35M | -18.85M | -25.22M | -29.08M | -40.74M | -29.38M | -29.25M | -41.09M | -36.43M | -34M | -46.99M | -38.81M | -53.63M | -40.47M | -40.16M | -31.84M | -33.53M |
Capital Expenditures | -500K | n/a | n/a | -953K | n/a | n/a | n/a | n/a | n/a | n/a | -40M | 1K | -1K | -875K | -47K | 1K | -95K | -4.06M | -127K | -68K | -106K | -5.25M | -12K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 875K | n/a | n/a | 39.6M | n/a | n/a | n/a | n/a | n/a | 100M |
Purchase of Investments | -48.79M | -85.69M | -42.2M | -20.35M | -267.85M | -26.95M | -33.52M | -66.38M | -135.62M | -66.31M | n/a | -40.65M | -169.19M | -75.43M | -69.64M | -100.42M | -101.08M | -10.96M | -39.48M | -68.73M | -93.77M | -64.93M | -297.54M |
Sales Maturities Of Investments | -23.87M | 156.75M | 99.25M | 51.65M | 61.5M | 80.99M | 58.33M | 87.54M | 45.31M | 57.75M | 70.05M | 63.29M | 74.5M | 124.5M | 92.68M | 59.64M | 61.48M | 51M | 112.13M | 69.05M | 156.66M | 83.7M | 51.84M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -875K | -4.52M | n/a | -39.6M | -4M | n/a | 7M | n/a | -5M | n/a |
Investing Cash Flow | -73.16M | 71.07M | 57.05M | 30.35M | -246.35M | 54.04M | 24.81M | 21.16M | -90.82M | -8.56M | 30.05M | 22.64M | -94.96M | 48.19M | 18.46M | -40.78M | -39.7M | 35.98M | 72.52M | 7.25M | 62.78M | 13.53M | -145.71M |
Debt Repayment | n/a | -11.2M | -4.29M | -5.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 609K | -9.72M | -8.46M | n/a | 645K | -889K | -1.54M | -818K | 2.49M | 146.18M | 4.24M | 2.42M | 24.37M | -1.31M | -133K | 3.23M | 41.59M | 37.5M | 399K | 105K | 413K | 383K | 3.85M |
Financial Cash Flow | -848K | -6.57M | -5.4M | -2.95M | 189.3M | -889K | 32.5M | 38.33M | 2.49M | 146.18M | 4.24M | 2.42M | 73.04M | -965K | -133K | 17.37M | 158.56M | 37.5M | 399K | 100K | 413K | 383K | 165.59M |
Net Cash Flow | -24.96M | 11.39M | 7.84M | 2.22M | -83.36M | 29.55M | 16.96M | 41.62M | -114.15M | 108.24M | -6.52M | -4.51M | -51.09M | 6.02M | -18.02M | -57.41M | 71.88M | 34.67M | 19.29M | -33.12M | 23.03M | -17.93M | -13.66M |
Free Cash Flow | 40.62M | -53.34M | -44.19M | -26.34M | -26.62M | -23.31M | -40.35M | -18.85M | -25.22M | -29.08M | -80.74M | -29.38M | -29.25M | -41.97M | -36.48M | -34M | -47.08M | -42.87M | -53.76M | -40.54M | -40.27M | -37.09M | -33.54M |
Adj. Free Cash Flow | 38.7M | -102.49M | -67.28M | -45.61M | -45.43M | -39.19M | -53.21M | -29.4M | -36.22M | -39.43M | -88.51M | -38.06M | -37.86M | -50.86M | -42.86M | -39.29M | -51.88M | -48.01M | -58.37M | -45.22M | -45.53M | -42.76M | -38.73M |
Maintenance CapEx | -248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38.4M | 2K | n/a | n/a | n/a | 2K | n/a | n/a | n/a | n/a | n/a | -3.69M | n/a |
Growth CapEx | -252K | n/a | n/a | -953K | n/a | n/a | n/a | n/a | n/a | n/a | -1.6M | -1K | -1K | -875K | -47K | -1K | -95K | -4.06M | -127K | -68K | -106K | -1.56M | -12K |
Owner Earnings | 40.88M | -53.34M | -44.19M | -25.39M | -26.62M | -23.31M | -40.35M | -18.85M | -25.22M | -29.08M | -79.15M | -29.38M | -29.25M | -41.09M | -36.43M | -34M | -46.99M | -38.81M | -53.63M | -40.47M | -40.16M | -35.53M | -33.53M |
Add to Watchlist
Select watchlists to add or remove RYTM